Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer

Background Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. Meth...

ver descrição completa

Detalhes bibliográficos
Principais autores: Dutt, Amit, Ramos, Alex H., Hammerman, Peter S., Mermel, Craig H., Cho, Jeonghee, Sharifnia, Tanaz, Chande, Ajit, Tanaka, Kumiko Elisa, Stransky, Nicolas, Greulich, Heidi, Gray, Nathanael S., Meyerson, Matthew L.
Outros Autores: Whitaker College of Health Sciences and Technology
Formato: Artigo
Idioma:en_US
Publicado em: Public Library of Science 2011
Acesso em linha:http://hdl.handle.net/1721.1/66570

Internet

http://hdl.handle.net/1721.1/66570

Registros relacionados